About Global Typhoid Fever

Updated February 16, 2023

Typhoid Fever is a Serious Illness That Can Be Prevented

A young boy in a hospital bed sick with typhoid fever. An adult hand rests on his forehead. Bangladesh, 2016.

A child with typhoid fever at a hospital in Bangladesh, 2016. Credit: Sabin Vaccine Institute/Das.

Typhoid fever is a serious illness caused by the Salmonella enterica serotype Typhi (S. Typhi) bacterium that spreads through contaminated water or food. Symptoms of typhoid fever infection include a sustained high fever, headache, weakness, stomach pain, diarrhea or constipation, cough, and loss of appetite. Without treatment, it can lead to severe complications such as gastrointestinal bleeding, septic shock, and death.

Typhoid fever can be treated with antibiotics. However, the overuse and misuse of antibiotics has led to widespread occurrence of antibiotic-resistant strains of S. Typhi. Extensively drug resistant (XDR) strains are beginning to appear, such as the ongoing XDR S. Typhi epidemic in Pakistan since 2016. It can be harder to treat people with typhoid fever caused by a multi-drug resistant or XDR strain of the bacterium because there are fewer antibiotic options that may be hard to access.

Safe and Effective Vaccines Can Help Prevent Typhoid Fever

An adolescent girl receives a typhoid vaccine in Pakistan, 2019.

A young woman receives a typhoid vaccine in Pakistan, 2019. Credit: TyVAC/PHC Global/Khan.

Typhoid fever can be prevented by vaccination, access to safe water and adequate sanitation, health education, and appropriate hygiene among food handlers.

Typhoid fever vaccines have been recommended by the World Health Organization (WHO) since 2008 for use in areas where typhoid fever is endemic (local transmission) or occurs in recurrent outbreaks. The typhoid conjugate vaccine (TCV) offers better and longer protection than the two other types of typhoid fever vaccines. Approved by the WHO in 2017, TCV is recommended as a single dose for persons aged 6 months to 45 years.

To accelerate control of typhoid fever in countries where burden or drug resistance is high, the WHO recommends:

  • Routine TCV administration to children at 9 months of age or up to 2 years of age
  • Catch-up campaigns for children up to 15 years of age at the time of TCV introduction into the routine program, when feasible

Recent studies show that TCV is 79%-95% effective at preventing typhoid fever infection and illness.

Typhoid Fever is Common in Many Countries and Affects Millions of People

Typhoid fever is a significant public health problem in many low- and middle-income countries, especially in areas with poor water supply and sanitation systems.

In 2019, over 9 million typhoid fever cases occurred globally, causing over 110,000 deaths. Most cases occur in South Asia, Southeast Asia, and Sub-Saharan Africa. Typhoid fever is likely underreported because it can be mistaken for other illnesses that produce fever, many affected people might not seek healthcare, and it requires a blood culture to confirm.

Up to 5% of people with typhoid fever can become chronic carriers, meaning they are able to spread the disease to their community over long periods of time. Chronic carriers may not know they are spreading the bacteria.

CDC’s Division of Foodborne, Waterborne, and Environmental Diseases site has additional information about typhoid fever.